Park Place Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Buy
1,139
+1
+0.1% +$423 0.07% 162
2026
Q1
$539K Sell
1,138
-78
-6% -$39.3K 0.11% 116
2025
Q4
$568K Sell
1,216
-2
-0.2% -$929 0.12% 114
2025
Q3
$519K Hold
1,218
0.11% 118
2025
Q2
$474K Buy
1,218
+1,168
+2,336% +$421K 0.11% 125
2025
Q1
$17.3K Hold
50
﹤0.01% 488
2024
Q4
$15K Hold
50
﹤0.01% 520
2024
Q3
$20.3K Hold
50
0.01% 511
2024
Q2
$16.1K Hold
50
0.01% 541
2024
Q1
$16.7K Hold
50
0.01% 566
2023
Q4
$13.5K Sell
50
-136
-73% -$33.6K 0.01% 586
2023
Q3
$45.8K Sell
186
-3
-2% -$821 0.01% 485
2023
Q2
$57.4K Sell
189
-20
-10% -$5.56K 0.02% 467
2023
Q1
$55.1K Sell
209
-33
-14% -$8.38K 0.02% 465
2022
Q4
$58K Buy
+242
New +$54.2K 0.02% 458

Other funds holding HCA

Park Place Capital's HCA Position: Q2 2026 in Review

Park Place Capital increased its HCA Healthcare (HCA) stake by 0.09% in Q2 2026, buying an estimated $423 and bringing the position to 1,139 shares worth $444K. The position accounts for 0.07% of the portfolio, ranked #162.

Park Place Capital first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $568K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Park Place Capital held 1,139 shares of HCA Healthcare worth $444K as of Q2 2026.
  • Park Place Capital bought 1 HCA Healthcare share in Q2 2026, an estimated $423.
  • HCA Healthcare made up 0.07% of Park Place Capital's portfolio in Q2 2026, its #162 holding.
  • Park Place Capital first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's HCA Healthcare position peaked at $568K in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.